Karina Sandgaard Kristensen

Karina Sandgaard Kristensen has extensive experience in research and development, primarily focused on the pharmaceutical and biochemical sectors. Currently serving in R&D Manufacturing Development at Novo Nordisk Pharmatech A/S since May 2011, Karina specializes in stable process development and cross-functional collaboration. Previous roles include R&D Scientist, where collaboration with Novozymes A/S and Novo Nordisk Cell Therapy involved enzyme screening and purification development, and positions in FeF Chemicals A/S, Novo Nordisk, and Dako, focusing on production support, purification processes, and cancer diagnostics. An academic background includes an M.Sc. in Cell Biology from the University of Southern Denmark.